MD's Aroon Indicator triggered a bullish signal on June 30, 2022. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 182 similar instances where the Aroon Indicator showed a similar pattern. In 128 of the 182 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 70%.
The Momentum Indicator moved above the 0 level on June 23, 2022. You may want to consider a long position or call options on MD as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
MD moved above its 50-day moving average on June 23, 2022 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MD crossed bullishly above the 50-day moving average on June 28, 2022. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MD advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MD broke above its upper Bollinger Band on June 27, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.186) is normal, around the industry mean (4.054). P/E Ratio (23.148) is within average values for comparable stocks, (56.669). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.766). MD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.025). P/S Ratio (0.968) is also within normal values, averaging (93.559).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of medical services
A.I.dvisor indicates that over the last year, MD has been loosely correlated with SGRY. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MD jumps, then SGRY could also see price increases.
|SGRY - MD|
|CYH - MD|
|THC - MD|
|ACHC - MD|
|SEM - MD|